The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Robin Kraak
Showing 1-9 of 9 articles
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer L,
Renkens M,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Garcia-Garcia H,
Kraak R,
Piek J,
Tijssen J,
Henriques J,
de Winter R,
Wykrzykowska J
March 18, 2022 | 10.4244/EIJ-D-21-00419
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R,
Tijssen R,
van Dongen I,
Elias J,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Tijssen J,
Piek J,
de Winter R,
Henriques J,
Wykrzykowska J
December 4, 2020 | 10.4244/EIJ-D-18-00884
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout K,
Kraak R,
Weevers A,
Piek J,
de Winter R,
Tijssen J,
Henriques J,
Wykrzykowska J,
Ijsselmuiden A,
Kauer F,
Beijk M,
Vis M,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI
Tijssen R,
Kraak R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Elias J,
van Dongen I,
Koch K,
Baan Jr J,
Vis M,
de Winter R,
Piek J,
Tijssen J,
Henriques J,
Wykrzykowska J
July 20, 2018 | 10.4244/EIJ-D-18-00335
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial
Tijssen R,
Kraak R,
Elias J,
van Dongen I,
Kalkman D,
Nassif M,
Sotomi Y,
Asano T,
Katagiri Y,
Collet C,
Piek J,
Henriques J,
de Winter R,
Tijssen J,
Onuma Y,
Serruys P,
Wykrzykowska J
July 20, 2018 | 10.4244/EIJ-D-17-01152
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria
Kraak R,
Grundeken M.J,
Hassell M,
Elias J,
Koch K,
Henriques J,
Piek J,
Baan Jr J,
Vis M,
Thijssen J,
de Winter R,
Wykrzykowska J
August 5, 2016 | 10.4244/EIJV12I5A95
Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography
Grundeken M.J,
Hassell M,
Kraak R,
de Bruin D,
Koch K,
Henriques J,
van Leeuwen T,
Thijssen J,
Piek J,
de Winter R,
Wykrzykowska J
December 20, 2015 | 10.4244/EIJY14M08_15
The future of BRS in bifurcations
Kraak R,
Grundeken M.J,
Onuma Y,
Tu S,
Wykrzykowska J,
Chevalier B,
Ormiston J,
Serruys P
May 19, 2015 | 10.4244/EIJV11SVA45
Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry
Kraak R,
Hassell M,
Grundeken M.J,
Koch K,
Henriques J,
Piek J,
Baan Jr J,
Vis M,
Arkenbout EK,
Thijssen J,
de Winter R,
Wykrzykowska J
February 20, 2015 | 10.4244/EIJY14M08_08
1
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke